Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Burnet Institute
Street 1: 85 Commercial Rd
Street 2:
City: Melbourne
Province: Victoria
Post Code: 3004
Country: Australia
Phone: 0392822111
Email: info@burnet.edu.au
Web Site: http://www.burnet.edu.au

Focal Point Contact Information

Salutation: Mr
First Name: Paul
Last Name: Rathbone
Title: Head Public Affairs and Development
Email: prathbone@burnet.edu.au
Phone: 0392822113

Alternate Focal Point Contact Information

Salutation: Mr
First Name: Jason
Last Name: Smith
Title: Development Manager
Email: jsmith@burnet.edu.au
Phone: 03850612401

General Information

Board Constituency: Developed Country NGO
Organization Type - Primary: Non-Governmental Organization
Organization Type - Secondary: Other Non-Governmental Organization (NGO)
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Burnet Institute is committed to reduce the suffering caused by TB and pursue the goal of a TB free world.
Burnet’s TB program include:
1. An assessment of drug-resistant TB in the Western Province of Papua New Guinea, partnering with the PNG National Department of Health, Australian Aid and other development partners.

Burnet is a partner in a multi-stakeholder response to the major tuberculosis (TB) epidemic in Western Province, Papua New Guinea (PNG).
Reducing the Impact of Drug-Resistant Tuberculosis (RID-TB), is a project funded by the Australian Aid program via the Department of Foreign Affairs and Trade (DFAT). Burnet is responding as the technical lead in the design, monitoring and implementation of a comprehensive strategy to mitigate the TB epidemic and care for people affected.

2. Comprehensive community-based prevention and care for drug-resistant tuberculosis, South Dagon, Myanmar
This project aims to implement and evaluate a model of community based drug-resistant tuberculosis (DR-TB) care to facilitate scale-up in Myanmar and other similar resource-constrained settings.

3. Healthy Mothers, Healthy Babies program is a research program which is addressing the high maternal and newnorn death rates in PNG and as part of this program the impact of infectious diseases such as TB.
burnet.edu.au/centres/18

4. Australasian Tuberculosis Forum
Burnet is part of this initiative which aims to create closer connections between the broad range of policy makers, clinicians, patients, scientists and public health workers working for tuberculosis control and elimination in our region. tuberculosisforum.com
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? >$10 MIL
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
We are in contact with the NTPs for PNG, Timor-Leste, and Myanmar. We are also a major contributor to the newly formed Australasian TB Forum, which is an association that aims to facilitate greater connection between and recognition for the broad range of policy makers, clinicians, patients, scientists and public health workers working for tuberculosis control and elimination in our region.
 

Geographical Reach

Which country is your headquarters located in: Australia
Which WHO region is the main focus of your work: Western Pacific
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Australia
China
Democratic Republic of Timor-Leste
Fiji
Lao People's Democratic Republic
Papua New Guinea
Thailand
Zimbabwe

Specializations

Research and Development
Technical Assistance

Specializations in Countries

Research and Development Australia
Research and Development China
Research and Development Democratic Republic of Timor-Leste
Research and Development Fiji
Research and Development Lao People's Democratic Republic
Research and Development Papua New Guinea
Research and Development Thailand
Research and Development Zimbabwe

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:

Comprehensive community-based prevention and care for drug-resistant tuberculosis, South Dagon, Myanmar

This project aims to implement and evaluate a model of community based drug-resistant tuberculosis (DR-TB) care to facilitate scale-up in Myanmar and other similar resource-constrained settings.

The project is; (i) providing all 60 existing multi drug-resistant TB (MDR-TB) patients with treatment support for at least 9 months of the first year; (ii) reducing the burden on the health system and enabling treatment and care for more MDR-TB patients diagnosed but not currently enrolled.

Key objectives are:

To build the capacity of township health system in delivering and co-ordinating MDR-TB prevention and care.
To deliver quality community-based MDR-TB prevention and care services through community-based treatment supporters.
Improved community and health facility based TB/MDR-TB infection control, TB preventative activities and education
Measure the impact, effectiveness and feasibility of the model of care through monitoring and evaluation and operational research


Drug-Resistant TB:
We are conducting epidemiological studies to determine the best strategies to scale up DR-TB in high burden settings.
Reducing the Impact of Drug-Resistant Tuberculosis (RID-TB), is a project funded by the Australian Aid program via the Department of Foreign Affairs and Trade (DFAT). Through this project Burnet is responding as the technical lead in the design, monitoring and implementation of a comprehensive strategy to mitigate the TB epidemic and care for people affected.

TB-HIV:
We are building country capacity in TB-HIV care by conducting clinical training.

Laboratory Strengthening:
We are assisting the national TB program of Timor-Leste scale up TB diagnostics and implement geneXpert.

New Diagnostics:
Burnet received a tuberculosis (TB) biomarkers grant through the Bill & Melinda Gates Foundation’s Grand Challenges in Global Health program, an initiative which seeks to overcome persistent bottlenecks in creating new tools that can radically improve health in the developing world.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: November 22, 2013
Last updated: September 9, 2016